Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Rebecca S Gelman"'
Publikováno v:
PLoS Pathogens, Vol 7, Iss 12, p e1002436 (2011)
While the contribution of CD8⁺ cytotoxic T lymphocytes to early containment of HIV-1 spread is well established, a role for NK cells in controlling HIV-1 replication during primary infection has been uncertain. The highly polymorphic family of KIR
Externí odkaz:
https://doaj.org/article/0ad80daa820e4cb8a48a92f6e2739cd4
Autor:
So-Yon Lim, Tiffany Chan, Rebecca S Gelman, James B Whitney, Kara L O'Brien, Dan H Barouch, David B Goldstein, Barton F Haynes, Norman L Letvin
Publikováno v:
PLoS Genetics, Vol 6, Iss 6, p e1000997 (2010)
CCL3 is a ligand for the HIV-1 co-receptor CCR5. There have recently been conflicting reports in the literature concerning whether CCL3-like gene (CCL3L) copy number variation (CNV) is associated with resistance to HIV-1 acquisition and with both vir
Externí odkaz:
https://doaj.org/article/60c4dc61353044759a39108016bac706
Autor:
Jose Pablo Leone, Kyrre E. Emblem, Michelle Weitz, Rebecca S. Gelman, Bryan P. Schneider, Rachel A. Freedman, Jerry Younger, Marco C. Pinho, A. Gregory Sorensen, Elizabeth R. Gerstner, Gordon Harris, Ian E. Krop, Daniel Morganstern, Jessica Sohl, Jiani Hu, Elizabeth Kasparian, Eric P. Winer, Nancy U. Lin
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-12 (2020)
Abstract Background We aimed to examine the safety and efficacy of bevacizumab and carboplatin in patients with breast cancer brain metastases. Methods We enrolled patients with breast cancer and > 1 measurable new or progressive brain metastasis. Pa
Externí odkaz:
https://doaj.org/article/04de20311a7a49dab14a302103b2d131
Autor:
Jing, Xu, Tanya E, Keenan, Beth, Overmoyer, Nadine M, Tung, Rebecca S, Gelman, Karleen, Habin, Judy E, Garber, Leif W, Ellisen, Eric P, Winer, Paul E, Goss, Beow Y, Yeap, Bruce A, Chabner, Steven J, Isakoff
Publikováno v:
Breast cancer research and treatment. 189(3)
We evaluated the efficacy and safety of poly-(adenosine diphosphate-ribose) polymerase (PARP) 1 and 2 inhibitor veliparib and temozolomide in metastatic breast cancer patients with and without germline BRCA1/2 mutations.In this single-arm phase II tr
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 8, Iss 9 (2012)
PLoS Pathogens, Vol 8, Iss 9 (2012)
Autor:
William T, Shearer, Howard M, Rosenblatt, Rebecca S, Gelman, Rebecca, Oyomopito, Susan, Plaeger, E Richard, Stiehm, Diane W, Wara, Steven D, Douglas, Katherine, Luzuriaga, Elizabeth J, McFarland, Ram, Yogev, Mobeen H, Rathore, Wende, Levy, Bobbie L, Graham, Stephen A, Spector
Publikováno v:
The Journal of allergy and clinical immunology. 112(5)
Peripheral blood lymphocyte subsets need to be determined in a large, urban, minority-predominant cohort of healthy children to serve as suitable control subjects for the interpretation of the appearance of these cells in several disease conditions,
Autor:
Beverly E, Sha, Hernan, Valdez, Rebecca S, Gelman, Alan L, Landay, Jan, Agosti, Ronald, Mitsuyasu, Richard B, Pollard, Donna, Mildvan, Ann, Namkung, Debra M, Ogata-Arakaki, Lawrence, Fox, Scharla, Estep, Alejo, Erice, Patrick, Kilgo, Robert E, Walker, Lynne, Bancroft, Michael M, Lederman
Publikováno v:
AIDS research and human retroviruses. 18(9)
The effect of etanercept, a soluble p75 tumor necrosis factor (TNF) receptor:Fc fusion protein (Enbrel; Immunex, Seattle, WA) on plasma cytokines was evaluated in 11 HIV-infected subjects receiving highly active antiretroviral therapy (HAART) for 28
Autor:
Jennifer R. Bellon, Lawrence N. Shulman, Steven E. Come, Xiaochun Li, Rebecca S. Gelman, Barbara J. Silver, Jay R. Harris, Abram Recht
Publikováno v:
Cancer (0008543X); 4/1/2004, Vol. 100 Issue 7, p1358-1364, 7p
Autor:
C. Anika Bresk, Tamara Hofer, Sarah Wilmschen, Marina Krismer, Anja Beierfuß, Grégory Effantin, Winfried Weissenhorn, Michael J. Hogan, Andrea P. O. Jordan, Rebecca S. Gelman, David C. Montefiori, Hua-Xin Liao, Joern E. Schmitz, Barton F. Haynes, Dorothee von Laer, Janine Kimpel
Publikováno v:
Viruses, Vol 11, Iss 2, p 159 (2019)
A chimeric vesicular stomatitis virus with the glycoprotein of the lymphocytic choriomeningitis virus, VSV-GP, is a potent viral vaccine vector that overcomes several of the limitations of wild-type VSV. Here, we evaluated the potential of VSV-GP as
Externí odkaz:
https://doaj.org/article/3f55189d3d90403697d27d65e4a9d765
Publikováno v:
PLoS Pathogens, Vol 8, Iss 9 (2012)
Externí odkaz:
https://doaj.org/article/cf96ef53fb094e97a5d93160510e619a